Wellington Management Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Wellington Management Group's BMY Position: Q2 2026 in Review
Wellington Management Group reduced its Bristol-Myers Squibb (BMY) stake by 29% in Q2 2026, selling an estimated $91.5M and leaving 3,914,086 shares worth $226M. The position accounts for 0.04% of the portfolio, ranked #361.
Wellington Management Group first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.53B in Q2 2016. 2,519 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Wellington Management Group held 3,914,086 shares of Bristol-Myers Squibb worth $226M as of Q2 2026.
- Wellington Management Group sold 1,592,910 Bristol-Myers Squibb shares in Q2 2026, an estimated $91.5M.
- Bristol-Myers Squibb made up 0.04% of Wellington Management Group's portfolio in Q2 2026, its #361 holding.
- Wellington Management Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Wellington Management Group's Bristol-Myers Squibb position peaked at $9.53B in Q2 2016.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.